Pilot Study of UWNKG2D CAR-T in Treating Patients With Recurrent Glioblastoma
Latest Information Update: 04 Jan 2024
Price :
$35 *
At a glance
- Drugs NKG2D CAR T cell therapy-UWELL Biopharma (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- Sponsors UWELL Biopharma
- 01 Feb 2021 New trial record